Published by
@ShahidNShah
@ShahidNShah
ADC Pharmacokinetics & Clinical Pharmacology Summit is held on 8-10 October 2024.Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in development. Despite their success, the therapeutic window remains relatively narrow, posing challenges for finding an optimal dose.In the face of evolving regulatory guidance and more complex ADCs entering development, the inaugural ADC Pharmacokinetics and Clinical Pharmacology Summit comes to life this October to provide in-depth pharmacokinetic and clinical pharmacology insights to help ADC developers select a clinical dose that maximizes efficacy whilst limiting toxicities and drive more ADCs to BLA approval quicker.
[Read on adc-pharmacokinetics.com](https://adc-pharmacokinetics.com/take-part/register/)
Continue reading at adc-pharmacokinetics.com
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Sep 13, 2024 at 11:52am